Vildagliptin
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Vildagliptin Product Information
Vildagliptin is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Vildagliptin. The product is supplied by Clearsynth under CAT No. CS-O-10170.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Vildagliptin
CAS No.
274901-16-5
CAT No.
CS-O-10170
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C17H25N3O2
Molecular Weight
303.40
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Vildagliptin is supplied with detailed characterization data compliant with regulatory guideline. Vildagliptin can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Vildagliptin.
Overview
"Glyptins are class of oral anti-hyperglycemic agents that inhibit dipeptidyl peptidase 4 (DPP-4), which can act as a serine exopeptidase. ASide from there use in type 2 diabetes, gliptins have positive cardiovascular and anti-inflammtatory effects. Antidi"
Synonyms
Vildagliptin
Application Notes
"Glyptins are class of oral anti-hyperglycemic agents that inhibit dipeptidyl peptidase 4 (DPP-4), which can act as a serine exopeptidase. ASide from there use in type 2 diabetes, gliptins have positive cardiovascular and anti-inflammtatory effects. Antidi"
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.